HOMA-IR: the insulin resistance marker your doctor might not be running

One math formula. Two cheap lab values. A surprisingly early read on metabolic drift.

TL;DR

• HOMA-IR turns fasting glucose and fasting insulin into a single number that estimates insulin resistance.
• It often flags metabolic drift years before fasting glucose or HbA1c looks abnormal.
• Most primary-care labs do not order fasting insulin by default — patients usually need to ask.

What it is

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a math formula introduced in the 1980s. It multiplies fasting glucose by fasting insulin, then divides by a constant. The output is a single number that estimates how hard the pancreas is working to keep blood sugar normal (Matthews et al., 1985). Lower is better.

How it works

Think of insulin as a delivery van moving glucose from the blood into cells. When cells start to resist the delivery (the lock on the door gets sticky), the pancreas sends more vans. Fasting glucose may still look normal — but only because more vans are working harder. HOMA-IR catches the extra vans before glucose climbs. That is why it often flags trouble years before standard panels do.

Who asks about it

People come to this topic after looking at a normal fasting-glucose result and still feeling like something is off — energy slumps, midsection weight gain, a family history of type 2 diabetes. Many find HOMA-IR mentioned in podcasts and want to know whether it is a real number or wellness folklore. The short answer: it is a real, decades-old measure used in research and increasingly in proactive primary care.

What the research says

HOMA-IR correlates well with more elaborate insulin-sensitivity tests in non-diabetic adults. The research gold standard is the euglycemic-hyperinsulinemic clamp (in plain English: a slow drip of insulin and glucose that measures how cells respond). HOMA-IR is widely used in trials because it is cheap, repeatable, and sensitive. Most reference ranges put a healthy value below about 1.5. Values above about 2.9 suggest more significant resistance. Thresholds vary by lab and population (Endocrine Society guidelines).

What to know before considering it

HOMA-IR is calculated, not run as its own test. The clinician needs to order both fasting glucose and fasting insulin on the same morning draw, after at least 8 hours without food. Acute illness, recent intense exercise, and oral contraceptives can shift the result. It is one input — a starting question, not a diagnosis.

The Halftime POV

If a number that costs a few dollars to add to a routine blood draw can flag metabolic drift years early, it deserves a place in the proactive playbook. Ask for it.

Related reading:

• Testosterone lab tests: total vs free vs bioavailable
• Estrogen, muscle, and metabolic health: the perimenopause connection
• GLP-1 and PCOS: the metabolic connection women keep asking about

FAQ

Q: What is HOMA-IR? A: HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is a simple formula that combines fasting glucose and fasting insulin into a single number that estimates how hard the pancreas is working to keep blood sugar normal.

Q: What is considered a healthy HOMA-IR? A: Most published thresholds put a healthy value below about 1.5. Values between 1.9 and 2.9 suggest mild insulin resistance, and values above about 2.9 suggest more significant resistance. Thresholds vary by lab and population.

Q: Why isn’t HOMA-IR a standard lab test? A: Most primary-care panels include fasting glucose but not fasting insulin. Without the insulin number, HOMA-IR cannot be calculated. Many clinicians need to be asked specifically to add fasting insulin to the order.

Q: Can I improve HOMA-IR? A: Insulin sensitivity is one of the most modifiable metabolic measures. Resistance training, better sleep, lower refined-carbohydrate intake, and meaningful weight changes all move the needle in published trials.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.

Sources

• Matthews DR et al., “Homeostasis model assessment: insulin resistance and beta-cell function,” Diabetologia (1985)
• Endocrine Society Clinical Practice Guidelines